Gastric cancer
Conditions
Interventions
Dayly administration of ELENTAL (300kcal) for 6 months from the start of adjuvant chemotherapy
Dayly administration of ELENTAL (300kcal) and Rikkunshito 7.5g for 6 months from the start of adjuvant ch
Sponsors
NPO corporation Digestive Disorder Support Organization (DDSO)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who received R0 resection by distal or proximal gastrectomy 2) Patients who will receive adjuvant chemotherapy 3) Patients with apptite loss or malnutrition on POD 7 4) Patients without severe complications (heart disease, pulmonary fibrosis, intestinal pneumonia, bleeding tendency) 5) Patients who will be alive for more than 6 months 6) Patients who can take oral nutrition 7) Patients whose age is more than 20 8) Patients who approved written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with another malignant neoplasm 2) Patients who received preoperative chemo- or radiotherapy 3) Patients with preoperative malnutrition (alb less than 3.0g per dl) 4) Patients who were administrated Kanpo 5) Patients with allergy of ELENTAL 6) Patients with history of Kanpo allergy 7) Patients with severe psychiatric disorder 8) Patients who was considered ineligible by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change rate of mascle mass 6 months after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| change rate of body weight and fat mass 6 months after intervention nutrition index compliance of adjuvant chemotherapy drug safty | — |
Countries
Japan
Contacts
Public ContactSachio Fushida
Kanazawa University Hospital Gastroenterological Surgery
Outcome results
None listed